Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30008709HIVENSG00000249915.9protein_codingPDCD6NoNo10016A0A024QZ42
A0A087WZ38
O75340
TVIS30079925HIVENSG00000249915.9protein_codingPDCD6NoNo10016A0A024QZ42
A0A087WZ38
O75340
TVIS30061662HIVENSG00000249915.9protein_codingPDCD6NoNo10016A0A024QZ42
A0A087WZ38
O75340
TVIS30061663HIVENSG00000249915.9protein_codingPDCD6NoNo10016A0A024QZ42
A0A087WZ38
O75340
TVIS30061664HIVENSG00000249915.9protein_codingPDCD6NoNo10016A0A024QZ42
A0A087WZ38
O75340
TVIS20002812HPVENSG00000249915.9protein_codingPDCD6NoNo10016A0A024QZ42
A0A087WZ38
O75340
TCGA Plot Options
Drug Information
GenePDCD6
DrugBank IDDB01593
Drug NameZinc
Target IDBE0005812
UniProt IDO75340
Regulation Type
PubMed IDs18997320
CitationsSuzuki H, Kawasaki M, Kakiuchi T, Shibata H, Wakatsuki S, Maki M: Crystallization and X-ray diffraction analysis of N-terminally truncated human ALG-2. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2008 Nov 1;64(Pt 11):974-7. doi: 10.1107/S1744309108030297. Epub 2008 Oct 31.
GroupsApproved; Investigational
Direct ClassificationHomogeneous transition metal compounds
SMILES[Zn]
PathwaysDihydropyrimidinase Deficiency; Rofecoxib Action Pathway; Losartan Action Pathway; AICA-Ribosiduria; Canavan Disease; Quinapril Action Pathway; Alkaptonuria; Eprosartan Action Pathway; gamma-Glutamyltransferase Deficiency; Pterine Biosynthesis; Sulindac Action Pathway; Rescinnamine Action Pathway; Piroxicam Action Pathway; Nabumetone Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); beta-Ureidopropionase Deficiency; Vitamin B6 Metabolism; Retinol Metabolism; Valsartan Action Pathway; Valdecoxib Action Pathway; Irbesartan Action Pathway; Adenosine Deaminase Deficiency; Hawkinsinuria; Methionine Metabolism; Ramipril Action Pathway; Benazepril Action Pathway; beta-Alanine Metabolism; Aspartate Metabolism; Diclofenac Action Pathway; Galactosemia
PharmGKBPA451956
ChEMBLCHEMBL1201279